Nektar Therapeutics reported $131.02M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agios Pharmaceuticals AGIO:US $ 60.65M 35.85M
ALKERMES ALKS:US $ 383.44M 17.6M
Amgen AMGN:US $ 14585M 1716M
Astrazeneca AZN:US $ 22222M 709M
Baxter International BAX:US $ 3344M 157M
Biogen BIIB:US $ 4211.6M 864.4M
Bluebird Bio BLUE:US $ 247.76M 41.45M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Cara Therapeutics CARA:US $ 15.17M 1.35M
Eisai 4523:JP Y 277934M 21917M
Eli Lilly And LLY:US $ 15093.2M 3379M
Esperion Therapeutics ESPR:US $ 82.64M 15.25M
Exelixis EXEL:US $ 255.33M 41.99M
Gilead Sciences GILD:US $ 10214M 509M
GlaxoSmithKline GSK:LN 21387M 1112M
Halozyme Therapeutics HALO:US $ 114.25M 6.83M
Immunogen IMGN:US $ 120.32M 14.03M
IONIS PHARMACEUT IONS:US $ 293.82M 1.28M
Ironwood Pharmaceuticals IRWD:US $ 134.37M 110.77M
Karyopharm Therapeutics KPTI:US $ 58.12M 3.88M
Macrogenics MGNX:US $ 69.92M 16.88M
Mirati Therapeutics MRTX:US $ 180.87M 103.76M
Nektar Therapeutics NKTR:US $ 131.02M 7.39M
Neurocrine Biosciences NBIX:US $ 212.9M 22.9M
Novartis NOVN:VX SF 29633M 527M
Sarepta Therapeutics SRPT:US $ 425.02M 60.29M
Seattle Genetics SGEN:US $ 433.83M 44.22M
Takeda 4502:JP Y 1644766M 128410M
Teva Pharmaceutical TEVA:IT 12.69B 602M
Xencor XNCR:US $ 45.96M 53.97M
YTE INCY:US $ 660.32M 36.44M